Dr. Muhamed Baljević is an Associate Professor of Medicine at Vanderbilt University Medical Center and a specialist in multiple myeloma and plasma cell disorders. He leads the Vanderbilt Multiple Myeloma and Amyloidosis programs and has extensive experience in clinical research, CAR-T therapy, stem cell transplantation and novel treatments. He serves on NCCN, ASH, IMF and ECOG-ACRIN committees and has led numerous national and international clinical trials.

Prof. Sinem Civriz Bozdağ, MD is Professor of Hematology at Koç University School of Medicine and a consultant hematologist at Koç University Hospital in Istanbul, Türkiye. She specializes in leukemia, lymphoma, hematopoietic stem cell transplantation, and innovative therapies for hematologic malignancies. As part of her advanced training, she completed a fellowship at Thomas Jefferson University in Philadelphia, USA, gaining valuable international experience in hematopoietic stem cell transplantation.

Dr. Feras Alfraih is a consultant in Adult Hematology and Stem Cell Transplantation and Executive Director of the Cancer Centre of Excellence at King Faisal Specialist Hospital and Research Centre. He is also an Associate Professor of Medicine at Alfaisal University and holds an MBA in International Healthcare Management. His career combines clinical expertise, healthcare leadership, research, and strategic management, with extensive experience in cancer care and hematopoietic stem cell transplantation.

Prof. Dr. Timur Cerić is a specialist in Internal Medicine and Medical Oncology and an Associate Professor at the Faculty of Medicine, University of Sarajevo. He has extensive clinical and academic experience in oncology and has served as Head of the Day Hospital Department at the Oncology Clinic of KCUS since 2018. He is a member of ESMO and AACR and has represented Bosnia and Herzegovina in several international oncology organizations and research initiatives.

Dr. Lejla Hodžić-Pilav is a pediatrician and pediatric hemato-oncologist at the Clinical Center University of Sarajevo (KCUS), where she serves as Head of the Pediatric Hemato-Oncology Department. She specializes in the treatment of children with hematological and malignant diseases and has extensive clinical experience in pediatric oncology. She completed her specialization in Pediatrics in 2020 and subsequently pursued subspecialization in Pediatric Hemato-Oncology.

Dr. Belma Pehlivanović is a pharmacist, pharmaceutical scientist, and Teaching and Research Assistant at the Faculty of Pharmacy, University of Sarajevo. She holds a PhD in Pharmaceutical Sciences, with research focused on curcumin, rosuvastatin, lipid metabolism, and their therapeutic effects. Her professional experience includes pharmaceutical development and drug stability analysis, while her academic work focuses on pharmacology, biomedical research, and pharmaceutical sciences.

Dr. Hazza Al Zahrani is a distinguished Saudi hematologist with extensive expertise in adult hematology, hematopoietic stem cell transplantation, hemostasis and thrombosis. He has held senior positions at King Faisal Specialist Hospital and Research Centre, including Deputy Director of the Cancer Centre of Excellence and Director of the Adult Hematology Fellowship Program. He has an extensive record of clinical research, academic teaching, international collaboration, and scientific publications in hematology and transplantation.

Dr. Emina Suljović-Hadžimešić, MD, PhD, is an adult haematologist at the Clinical Centre of the University of Sarajevo and Head of its EAHAD-certified Haemophilia Treatment Centre. Her expertise includes acute leukaemias, lymphoproliferative disorders, myeloproliferative neoplasms, haemostasis and thrombosis. She is also an Assistant Professor of Internal Medicine and Haematology and has extensive experience in clinical trials, research, and international professional collaboration.

Dr. Amina Hadžibeganović is a Medical Oncology Resident at the Clinical Center University of Sarajevo (KCUS) and a PhD student in Biomedicine and Healthcare at the University of Tuzla. She is an ESCO Fellow and member of ESMO and ESDO, with experience in international oncology clinical trials. Her research interests include lung and breast cancer, melanoma, immunotherapy, precision oncology, and artificial intelligence in oncology.

Dr. Emir Sokolović is a Medical Oncologist at the Clinic of Oncology, Clinical Center University of Sarajevo. His clinical and research interests include gastrointestinal and thoracic malignancies, sarcomas, rare cancers, real-world evidence, and artificial intelligence in oncology. He is the recipient of the ASCO IDEA Award 2026 and has completed an observership at Memorial Sloan Kettering Cancer Center in New York.